120 related articles for article (PubMed ID: 14517486)
61. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
Petersen LC
Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
[TBL] [Abstract][Full Text] [Related]
62. The effect of fibrin structure on fibrinolysis.
Gabriel DA; Muga K; Boothroyd EM
J Biol Chem; 1992 Dec; 267(34):24259-63. PubMed ID: 1447176
[TBL] [Abstract][Full Text] [Related]
63. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
64. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
65. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
Summaria L; Boreisha IG; Arzadon L; Robbins KC
Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
[No Abstract] [Full Text] [Related]
66. Bispecific monoclonal antibodies increase the fibrin-specific fibrinolytic activity of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA).
Bos R; Nieuwenhuizen W
Ann N Y Acad Sci; 1992 Dec; 667():428-30. PubMed ID: 1309066
[No Abstract] [Full Text] [Related]
67. Inhibition of plasminogen activation by polymerized ampicillin.
al-Roof Higazi A; Hermoni M; Aziza R; Mayer M
Thromb Res; 1994 Sep; 75(6):643-51. PubMed ID: 7831683
[TBL] [Abstract][Full Text] [Related]
68. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
69. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
70. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
71. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Husain SS
Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
[TBL] [Abstract][Full Text] [Related]
72. [Effect of antiphospholipid antibodies on the formation and lysis of fibrin network in patients with recurrent miscarriage].
Marchi R; Maya I; Garmendia J
Invest Clin; 2011 Mar; 52(1):35-47. PubMed ID: 21614812
[TBL] [Abstract][Full Text] [Related]
73. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
[TBL] [Abstract][Full Text] [Related]
74. Alpha 2-plasmin inhibitor deficiency.
Lipinski B; Gurewich V
Lancet; 1979 Feb; 1(8111):329. PubMed ID: 84984
[No Abstract] [Full Text] [Related]
75. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
76. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
77. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
[TBL] [Abstract][Full Text] [Related]
78. Dysregulated proteolysis in AIDS.
Auci DL; Durkin HG; Murali MR
Immunol Invest; 1992 Jul; 21(4):305-19. PubMed ID: 1398780
[TBL] [Abstract][Full Text] [Related]
79. Human cathepsins K, L, and S: Related proteases, but unique fibrinolytic activity.
Douglas SA; Lamothe SE; Singleton TS; Averett RD; Platt MO
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1925-1932. PubMed ID: 29944896
[TBL] [Abstract][Full Text] [Related]
80. Non-ionic detergents Nonidet P-40 and Triton X-100 increase enzymatic activity of plasmin.
Trinh THT; Kim J; Lee CH; Ryou C
Biochem Biophys Res Commun; 2019 Apr; 512(2):314-318. PubMed ID: 30890336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
